Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;6(7):2631-9.
doi: 10.1021/pr0700807. Epub 2007 May 23.

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling

Affiliations

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling

Paweena Kreunin et al. J Proteome Res. 2007 Jul.

Abstract

Current methods in the noninvasive detection and surveillance of bladder cancer via urine analysis include voided urine cytology (VUC) and some diagnostic urinary protein biomarkers; however, due to the poor sensitivity of VUC and high false-positive rates of currently available protein assays, detection of bladder cancer via urinalysis remains a challenge. In the study presented here, a rapid, high-sensitivity technique was developed to profile the N-linked glycoprotein component in naturally micturated human urine specimens. Concanavalin A (Con A) affinity chromatography coupled to nanoflow liquid chromatography was utilized to separate the complex peptide mixture prior to a linear ion trap MS analysis. Of 186 proteins identified with high confidence by multiple analyses, 40% were secreted proteins, 18% membrane proteins, and 14% extracellular proteins. In this study, the presence of several proteins appeared to be associated with the presence of bladder cancer, including alpha-1B-glycoprotein that was detected in all tumor-bearing patient samples but in none of the samples obtained from non-tumor-bearing individuals. The combination of Con A affinity chromatography and nano-LC/MS/MS provides an initial investigation of N-glycoproteins in complex biological samples and facilitates the identification of potential biomarkers of bladder cancer in noninvasively obtained human urine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) A representative nano-LC/MS/MS base peak chromatogram, showing the detection of the peptide ions across the 40 min gradient separation. (B) MS/MS sequencing data of a peptide from uromodulin, identified in the eluted fraction of a bladder-tumor-bearing patient urine sample.
Figure 2
Figure 2
Reproducibility of nano-LC/MS/MS of Con A-captured fractions from a human urine sample. The retention times of a +2 charged precursor mass of YFIDFVAR from the protein kinnogen-1 from three independent runs were measured to be 22.84, 22.73, and 22.83 min.
Figure 3
Figure 3
Subcellular location of proteins identified in naturally micturated urine samples using a Con A lectin column and MS/MS analysis. A total of 186 urinary proteins were identified.

References

    1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83(1):18–29. - PubMed
    1. Aben KK, Kiemeney LA. Epidemiology of bladder cancer. Eur Urol. 1999;36(6):660–72. - PubMed
    1. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol. 2000;164(3 Part 1):680–4. - PubMed
    1. Cajulis RS, Haines GK, 3rd, Frias-Hidvegi D, McVary K, Bacus JW. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn Cytopathol. 1995;13(3):214–23. discussion 224. - PubMed
    1. Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. Eur Urol. 2004;46(4):466–71. - PubMed

Publication types